British Dragon Pharma Mastabol 100

CONCLUSION

Mastabol 100 is identified as a 100 mg/ml injectable formulation of drostanolone propionate. The compound is a DHT-derived androgenic-anabolic steroid with androgen-receptor activity and a low tendency toward aromatization.

Bodybuilding literature commonly discusses drostanolone in relation to cutting and lean-mass phases, but non-medical athletic dosing is not an approved therapeutic standard. The dosing information presented above should therefore be understood as descriptive information about commonly reported bodybuilding protocols rather than an individualized medical recommendation.

Drostanolone binds the androgen receptor and produces androgenic effects. Its molecular structure does not undergo aromatization to estrogen in the same way as testosterone. This characteristic is relevant to its pharmacological profile but does not eliminate endocrine, cardiovascular, reproductive or androgenic risks. DrugBank information provides additional compound-level pharmacology.

Because androgenic-anabolic steroid exposure can affect endogenous testosterone production, cardiovascular markers, lipids, fertility and other physiological systems, appropriate health monitoring is an important consideration. There is also no universally validated PCT regimen that can guarantee hormonal recovery following non-medical anabolic-steroid use.

Disclaimer

This content is provided exclusively for educational and informational purposes. It does not constitute medical advice, treatment recommendations or endorsement of non-medical anabolic steroid use. Bodybuilding dosing information describes reported patterns rather than an approved therapeutic protocol. Anabolic-androgenic steroids can produce significant endocrine, cardiovascular, reproductive and androgenic effects. Readers should consult qualified healthcare professionals regarding medical questions, laboratory monitoring and applicable laws in their jurisdiction.

REFERENCES